Sales 2021 | 28.79M 31M 42.37M | Sales 2022 | 25.74M 27.72M 37.88M | Capitalization | 97.31M 105M 143M |
---|---|---|---|---|---|
Net income 2021 | 38M 40.92M 55.93M | Net income 2022 | -44M -47.39M -64.76M | EV / Sales 2021 | 2.79 x |
Net cash position 2021 | 3.61M 3.89M 5.31M | Net cash position 2022 | 4.88M 5.25M 7.18M | EV / Sales 2022 | 3.59 x |
P/E ratio 2021 |
2.18
x | P/E ratio 2022 |
-1.98
x | Employees | 92 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 32.4% |
Latest transcript on Biofrontera AG
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 21-12-13 | |
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 46 | 21-12-13 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |